Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 801 - 850 out of 7,343

Document Document Title
WO/2004/054954A1
A process for the purification of hydroxyaryl aldehydes and ketones comprising the following steps; 1) adding a mineral acid to a first composition comprising a hydroxyaryl aldehyde or a hydroxyaryl ketone; 2) washing the mixture obtaine...  
WO/2004/054961A1
A process for the preparation of substituted halogenated anilines from substituted halogenated 1-chlorobenzenes which comprisesa) reacting a substituted halogenated 1-chlorobenzene selectively with an imine in the presence of a transitio...  
WO/2004/053458A2
A process is described for producing one or more substituted iminoamines, in particular β-­unsaturated β-iminoamines, in a single reaction comprising reacting one or more primary amines, alkynes, and isonitriles in the presence of a t...  
WO/2004/052816A1
Compounds of formula (I), wherein A1 and A2 are each independently of the other a bond or a C1-C6alkylene bridge; A3 is a C1-C6alkylene bridge; X1 and X2 are each independently of the other fluorine, chlorine or bromine; Y is O, NR7, S, ...  
WO/2004/052847A2
The present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation comprising administering to a patient in need thereof an effective amount of a compound of the formula...  
WO2004014551A3
An immobilised nitrogen-containing ligand is described comprising the reaction product of a compound of formula (I) wherein R<5>, R<6>, R<7> and R<8> are independently hydrogen, a saturated or unsaturated C1-C10 alkyl group, an aryl grou...  
WO/2004/048395A1
Novel phosphorescent compound provided through synthesis of an ortho metal complex with the use of easily synthesized ligands. Further, there is provided an electroluminescent element of high luminescence efficiency with the use of the p...  
WO/2004/046087A1
Process for the preparation of an enantiomerically enriched Schiff base wherein an amine is contacted with a carbonyl compound wherein the amine and/or the carbonyl compound is a chiral compound, to form a mixture of the enantiomers of t...  
WO/2004/043908A1
A process for interconverting a mixture of cis-trans erythro-threo isomers of a compound of formula I into the substantially pure cis isomer. Cis isomers of formula I are usefull intermediates in the synthesis of cis isomers of benzamide...  
WO/2004/043884A2
Novel acylating agents useful for preparing activated nucleophiles such as terminally activated polymers are disclosed. In preferred aspects, the acylating agents are formula (I) and formula (II) and they used to prepare activated polyme...  
WO2003095701A8
The present invention relates to novel 1,3-diimine copper complexes and the use of 1,3-diimine copper complexes for the deposition of copper on substrates or in or on porous solids in an Atomic Layer Deposition process. This invention al...  
WO2003040096A3
Disclosed are compounds of the formula (I), wherein the variables RN, RC, R1, R25, R2, and R3 are as defined herein. These compounds have activity as inhibitors of betasecretase and are therefore useful in treating a variety of discorder...  
WO/2004/035551A2
The present invention is directed to novel fluorinated dye stabilizers having both high quenching efficiency and solubility in halogenated solvents. These dye stabilizers have shown a significantly effect on improving the dye fastness in...  
WO/2004/024677A1
An N-hydroxyformamidine derivative represented by the formula (I) wherein R1 represents hydrogen, C1-4 alkyl, C1-4 alkoxy, or halogeno; A represents C1-10 alkylene or a group represented by the formula (II) (wherein m, n, and p each is a...  
WO/2004/024737A1
The invention relates to a method for binding heteroatom-carbon bonds. According to said method, a lithium compound (II) is first generated by reacting aliphatic or aromatic halogen compounds (I) with lithium metal, said compound is then...  
WO/2004/022775A1
A method for identifying antibacterial agents comprises depleting bacteria of a strain comprising a luxAB construct of Ca2+, incubating the Ca2+ depleted bacteria with an agent the antibacterial effect of which shall be determined, recor...  
WO2003099192A3
The present invention relates to biphenylyl derivatives, processes for their production, their uses and pharmaceutical compositions containing them.  
WO2004010512A9
Novel heterodiamondoids are disclosed. These heterodiamondoids are diamondoids that include heteroatoms in the diamond lattice structure. The heteroatoms may be either electron donating, such that an n-type heterodiamondoid is created, o...  
WO2003006425A9
The present invention relates to compounds of the general formula (I); or salts thereof, as anti-inflammatory, immunomodulatory and anti-proliferatory agents.  
WO/2004/014551A2
An immobilised nitrogen-containing ligand is described comprising the reaction product of a compound of formula (I) wherein R5, R6, R7 and R8 are independently hydrogen, a saturated or unsaturated C1-C10 alkyl group, an aryl group, a ure...  
WO/2004/013088A1
The invention relates to polyaldimines which may be obtained from at least one polyamine (A) with aliphatic primary amino groups and at least one aldehyde (B). Said polyaldimines are odourless as are the aldehydes (B) produced by hydroly...  
WO2003099435A3
A vanadium catalyst and a process for cyanating an aldehyde are provided. The vanadium catalyst comprises a Vanadium(V) salen complex. The process comprises reacting the aldehyde with: i) a cyanide source which does not comprise a Si-CN ...  
WO/2004/010512A2
Novel heterodiamondoids are disclosed. These heterodiamondoids are diamondoids that include heteroatoms in the diamond lattice structure. The heteroatoms may be either electron donating, such that an n-type heterodiamondoid is created, o...  
WO2002070464A3
The invention relates to novel hydrazone derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compou...  
WO2003049690A3
The present invention relates to the inhibition of HIV integrase, and to the treatment of AIDS or ARC by administering compounds of the following formula, or a tautomer of said compound, or a pharmaceutically acceptable salt, solvate or ...  
WO/2004/002947A1
Compounds of formula (I), wherein R01 is hydrogen, C1-C8alkyl, C3-C8alkenyl or C3-C8alkynyl; or R01 is phenyl or phenyl-C1-C6alkyl, it being possible for the phenyl rings in turn to be mono- to penta-substituted by halogen and/or mono-, ...  
WO2002053522A3
The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant inventive are ligands for estrogen receptors and as such may be useful for t...  
WO/2004/002946A1
The invention relates to novel chelate complexes of calcium, strontium and barium. The ligands that, together with the metal cation, form the complex are beta-ketiminate compounds having a scorpion tail . The invention also relates to th...  
WO2003077828A3
The present invention relates to novel florfenicol compounds having the chemical structure (I) wherein the compounds are useful for the treatment and/or prevention of bacterial infections in a broad range of patients such as, without lim...  
WO2003063758A3
The present invention relates to non-classical cannabinoids that are ligands of the peripheral cannabinoid receptor CB2, and to pharmaceutical compositions thereof comprising as an active ingredient novel (+) alpha-pinene derivatives, wh...  
WO2003011846B1
There is described a process for the preparation of citalopram and of its pharmaceutically acceptable salts, which comprises treating a 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5 -isobenzofurancarbaldoxime, O-substitute...  
WO/2003/105751A2
The present invention relates to a novel curcumin derivative and a pharmaceutical composition, in particular to a novel curcumin derivative with anti-angiogenic activity and a pharmaceutical composition for treating or preventing a disea...  
WO/2003/101938A1
This invention relates to a oxamidination method of carbonyl compounds comprising reacting a liquid-phase reaction system containing carbonyl compounds, ammonia and hydrogen peroxide in the presence of silicon containing catalyst, which ...  
WO2002092552A3
The invention relates to compounds of the general Formula (I), wherein R3, R4, R5, R6, R7, R8, Ar2, Q1, Q2, a, b and n have the significances given in claim 1, and optionally the enantioners thereof. The active ingredients have advantage...  
WO/2003/099192A2
The present invention relates to biphenylyl derivatives, processes for their production, their uses and pharmaceutical compositions containing them.  
WO/2003/099435A2
A vanadium catalyst and a process for cyanating an aldehyde are provided. The vanadium catalyst comprises a Vanadium(V) salen complex. The process comprises reacting the aldehyde with: i) a cyanide source which does not comprise a Si-CN ...  
WO2003057169A3
The present invention pertains, at least in part, to novel substituted 4-dedimethylamino tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infect...  
WO2003011846A3
There is described a process for the preparation of citalopram and of its pharmaceutically acceptable salts, which comprises treating a 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5 -isobenzofurancarbaldoxime, O-substitute...  
WO/2003/097577A1
The invention relates to a filtering composition, particularly a cosmetic composition, which is used to protect a sensitive material against ultraviolet radiation, one such composition comprising an effective quantity of at least one nit...  
WO/2003/097580A1
A mixture of two or more diimonium salts or aminium salts obtained by oxidizing one or more compounds represented by the general formula (1); near-infrared absorption filters characterized by containing the mixture; and optical informati...  
WO2003014066A3
The invention relates to a novel method for producing 2-(hydroxyphenyl)-2-(alkoxyimino)-N-methylacetamide derivatives.  
WO2002100813A3
Disclosed is a compound represented by Structural Formula (I): Ar is a substituted or unsubstituted aromatic group. Q is a covalent bond, -CH2-or-CH2CH2-; W is a substituted or unsubstituted alkylene or a substituted or unsubstituted het...  
WO2003006425A3
The present invention relates to compounds of the general formula (I); or salts thereof, as anti-inflammatory, immunomodulatory and anti-proliferatory agents.  
WO/2003/095701A1
The present invention relates to novel 1,3-diimine copper complexes and the use of 1,3-diimine copper complexes for the deposition of copper on substrates or in or on porous solids in an Atomic Layer Deposition process. This invention al...  
WO2001040188A8
The present invention is directed to curcumin analogs (I), wherein Y is OH, halogen, or CF3; Z is H, OH, OR1, halogen, or CF3; X1 and X2 are independently C or N; and A is as defined in the application; exhibiting anti-tumor and anti-ang...  
WO/2003/091202A1
Diketohydrazine derivatives represented by the following general formula (I) (wherein each symbol is as defined in the description) and pharmaceutically acceptable salts thereof: (I) Because of having a cysteine protease inhibitory activ...  
WO/2003/091207A2
This invention provides a method of preparing amine stereoisomers, which comprises stereoselectively reducing a sulfinylimine that bears on the sulfmyl group a residue of an alcohol, thiol or amine, or reacting a sulfmylimine stereoisome...  
WO2002064136A3
The present invention relates to novel compounds (I), their prodrugs, and the pharmaceutically acceptable salts as well as pharmaceutical compositions containing such compounds useful in treating certain metabolic diseases and diseases m...  
WO/2003/087032A1
Compounds are described, having general formula (I) and their use as acaricides, insecticides and/or fungicides.  
WO2002076939A3
Compounds having quinone and quinone analogs useful for pharmaceutical preparations have now been found which inhibit cysteine proteases, in particular, caspases and 3C-cysteine proteases. The cysteine protease inhibitors of the present ...  

Matches 801 - 850 out of 7,343